НИИ Скорой помощи им. Н.В. Склифосовского ДЗМ
Москва, г. Москва и Московская область, Россия
Москва, г. Москва и Московская область, Россия
Москва, г. Москва и Московская область, Россия
Москва, г. Москва и Московская область, Россия
В статье рассматривается один из важнейших факторов, позволяющих определить возможность широкого и безопасного применения графеновых нанообъектов в современной биомедицине - это фактор биосовместимости, а именно взаимодействие графенсодержащего вещества с заданным участком организма, который реализуется на разных масштабах и на разных уровнях организации живой материи. Графен и его производные продемонстрировали исключительные свойства и потенциал для различных применений. Хотя производные графена, такие как оксид графена (GO), восстановленный оксид графена (rGO), немногослойный графен (FLG) и многослойный графен (MLG), обладают свойствами, сходными со свойствами графена, необходимы дополнительные исследования для решения проблемы масштабируемости и экономической эффективности для практических применений. В тканевой инженерии материалы на основе графена показали себя многообещающими в качестве каркасов, биосенсоров и систем доставки лекарств, но оптимизация стратегий биосовместимости и функционализации имеет решающее значение для безопасного и эффективного использования. Эта работа представляет собой попытку лучше понять сложные взаимодействия между графеном и биологическими системами, включая клетки, ткани и органы, что необходимо для будущих исследований и расширения использования графена в биомедицинских приложениях.
графен, биосовместимость, функционализация, биомедицинские приложения
1. Zhang Y.I., Zhang L., Zhou C. Graphene and Related Applications. Acc. Chem. Res., 2013, vol. 46, pp. 2329-2339.
2. Hummers W.S., Offeman R.E. Preparation of Graphitic Oxide. J. Am. Chem. Soc., 1958, vol. 80, no. 6, p. 1339, doi:https://doi.org/10.1021/ja01539a017.
3. Park S., Ruoff R.S. Chemical methods for the production of graphenes. Nat. Nanotechnol., 2009, vol. 4, no. 4, pp. 217-224, doi:https://doi.org/10.1038/nnano.2009.58.
4. Lu X., Yu M., Huang H., Ruoff R.S. Tailoring graphite with the goal of achieving single sheets. Nanotechnology, 1999, vol. 10, no. 3, pp. 269-272, doi:https://doi.org/10.1088/0957-4484/10/3/308.
5. Schwierz F. Graphene transistors. Nat. Nanotechnol., 2010, vol. 5, no. 7, pp. 487-496, doi:https://doi.org/10.1038/nnano.2010.89.
6. Hu W. et al. Graphene-based antibacterial paper. ACS Nano, 2010, vol. 4, no. 7, pp. 4317-4323, doi:https://doi.org/10.1021/nn101097v.
7. Lin L. et al. Size-dependent effects of suspended graphene oxide nanoparticles on the cellular fate of mouse neural stem cells. Int. J. Nanomedicine, 2020, vol. 15, pp. 1421-1435, doi:https://doi.org/10.2147/IJN.S225722.
8. Rasanani A.H., Kaffashi B., Seyfi J., Ahmadi S. Probing the effect of graphene surface chemistry on compatibility, crystallinity, and viscoelastic response of polylactic acid/polyvinylidene fluoride blends. Mater. Today Commun., 2022, vol. 30, no. January, p. 103188, doi:https://doi.org/10.1016/j.mtcomm.2022.103188.
9. Sontakke A.D., Tiwari S., Purkait M.K. A comprehensive review on graphene oxide-based nanocarriers: Synthesis, functionalization and biomedical applications. FlatChem, 2023, vol. 38, no. February, p. 100484, doi:https://doi.org/10.1016/j.flatc.2023.100484.
10. Rahman M. et al. Chapter 13 - Functionalized graphene-based nanomaterials for drug delivery and biomedical applications in cancer chemotherapy. Nanoparticles in Pharmacotherapy, 2019, pp. 429-460, doi: https://doi.org/10.1016/B978-0-12-816504-1.00011-9.
11. Samantara A.K., Acharya C., Satpathy D., Panda C.R., Bhaskara P.K., Sasmal A. Chapter 13 - Functionalized graphene: An unique platform for biomedical application. Fullerens, Graphenes and Nanotubes, 2018, pp. 545-584, doi:https://doi.org/10.1016/B978-0-12-813691-1.00013-0.
12. Maktedar S.S., Mehetre S.S., Avashthi G., Singh M. In situ sonochemical reduction and direct functionalization of graphene oxide: A robust approach with thermal and biomedical applications. Ultrason. Sonochem., 2017, vol. 34, pp. 67-77, doi:https://doi.org/10.1016/j.ultsonch.2016.05.015.
13. Luo Y. et al. Enhanced proliferation and osteogenic differentiation of mesenchymal stem cells on graphene oxide-incorporated electrospun poly(lactic-co-glycolic acid) nanofibrous mats. ACS Appl. Mater. Interfaces, 2015, vol. 7, no. 11, pp. 6331-6339, doi:https://doi.org/10.1021/acsami.5b00862.
14. Shanmugam D.K. et al. Efficacy of Graphene-Based Nanocomposite Gels as a Promising Wound Healing Biomaterial. Gels, 2022, vol. 9, no. 1, p. 22, doi:https://doi.org/10.3390/gels9010022.
15. Qu G. et al. Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages. ACS Nano, 2013, vol. 7, no. 7, pp. 5732-5745, doi:https://doi.org/10.1021/nn402330b.
16. Jasim D.A. et al. The impact of graphene oxide sheet lateral dimensions on their pharmacokinetic and tissue distribution profiles in mice. J. Control. Release, 2021, vol. 338, no. August, pp. 330-340, doi:https://doi.org/10.1016/j.jconrel.2021.08.028.
17. Wu J., Yang R., Zhang L., Fan Z., Liu S. Cytotoxicity effect of graphene oxide on human MDA-MB-231 cells. Toxicol. Mech. Methods, 2015, vol. 25, no. 4, pp. 312-319, doi:https://doi.org/10.3109/15376516.2015.1031415.
18. Tu Z. et al. Combination of Surface Charge and Size Controls the Cellular Uptake of Functionalized Graphene Sheets. Adv. Funct. Mater., 2017, vol. 27, no. 33, doi:https://doi.org/10.1002/adfm.201701837.
19. Cheng C. et al. Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors. J. Mater. Chem. B, 2013, vol. 1, no. 3, pp. 265-275, doi:https://doi.org/10.1039/c2tb00025c.
20. Qi Z. et al. Enhancement of neural stem cell survival, proliferation and differentiation by IGF-1 delivery in graphene oxide-incorporated PLGA electrospun nanofibrous mats. RSC Adv., 2019, vol. 9, no. 15, pp. 8315-8325, doi:https://doi.org/10.1039/c8ra10103e.
21. Devi Y.G.V., Nagendra A.H., Shenoy S.P., Chatterjee K., Venkatesan J. Fucoidan-Incorporated Composite Scaffold Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells for Bone Tissue Engineering. Mar. Drugs, 2022, vol. 20, no. 10, doi:https://doi.org/10.3390/md20100589.
22. Priyadarsini S., Mohanty S., Mukherjee S., Basu S., Mishra M. Graphene and graphene oxide as nanomaterials for medicine and biology application. J. Nanostructure Chem., 2018, vol. 8, no. 2, pp. 123-137, doi:https://doi.org/10.1007/s40097-018-0265-6.
23. Feng R., Yu F., Xu J., Hu X. Knowledge gaps in immune response and immunotherapy involving nanomaterials: Databases and artificial intelligence for material design. Biomaterials, 2020, vol. 266, no. October, p. 120469, doi:https://doi.org/10.1016/j.biomaterials.2020.120469.
24. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett., 2010, vol. 10, no. 9, pp. 3318-3323, doi:https://doi.org/10.1021/nl100996u.
25. Liu Y. et al. Single-layer graphene enhances the osteogenic differentiation of human mesenchymal stem cells in vitro and in vivo. J. Biomed. Nanotechnol., 2016, vol. 12, no. 6, pp. 1270-1284, doi:https://doi.org/10.1166/jbn.2016.2254.
26. Pourmadadi M., Shayeh J.S., Arjmand S., Omidi M., Fatemi F. An electrochemical sandwich immunosensor of vascular endothelial growth factor based on reduced graphene oxide/gold nanoparticle composites. Microchem. J., 2020, vol. 159, no. June, p. 105476, doi:https://doi.org/10.1016/j.microc.2020.105476.
27. Zhu S., Liu Y., Gu Z., Zhao Y. Research trends in biomedical applications of two-dimensional nanomaterials over the last decade – A bibliometric analysis. Adv. Drug Deliv. Rev., 2022, vol. 188, p. 114420, doi:https://doi.org/10.1016/j.addr.2022.114420.
28. Machova I. et al. The bio-chemically selective interaction of hydrogenated and oxidized ultra-small nanodiamonds with proteins and cells. Carbon N.Y., 2020, vol. 162, pp. 650-661, doi:https://doi.org/10.1016/j.carbon.2020.02.061.
29. Cosnier S. et al. Biocompatible Graphene Oxide-Based Glucose Biosensors. J. Biosens. Bioelectron, 2010, vol. 26, no. 9, p. 4785, doi:https://doi.org/10.1021/la100886x.
30. Cellot G. et al. Bonding of Neuropeptide Y on Graphene Oxide for Drug Delivery Applications to the Central Nervous System. ACS Appl. Nano Mater., 2022, vol. 5, no. 12, pp. 17640-17651, doi:https://doi.org/10.1021/acsanm.2c03409.
31. Rhazouani A. et al. Synthesis and Toxicity of Graphene Oxide Nanoparticles: A Literature Review of in Vitro and in Vivo Studies. Biomed Res. Int., 2021, vol. 2021, doi:https://doi.org/10.1155/2021/5518999.
32. Dvir T., Timko B.P., Kohane D.S., Langer R. Nanotechnological strategies for engineering complex tissues. Nat. Nanotechnol., 2011, vol. 6, no. 1, pp. 13-22, doi:https://doi.org/10.1038/nnano.2010.246.
33. Raslan A., Saenz del Burgo L., Ciriza J., Luis Pedraz J. Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. Int. J. Pharm., 2020, vol. 580, no. December 2019, p. 119226, doi:https://doi.org/10.1016/j.ijpharm.2020.119226.
34. Kurantowicz N. et al. Biodistribution of a High Dose of Diamond, Graphite, and Graphene Oxide Nanoparticles After Multiple Intraperitoneal Injections in Rats. Nanoscale Res. Lett., 2015, vol. 10, no. 1, doi:https://doi.org/10.1186/s11671-015-1107-9.
35. Novoselov K.S., Fal′ko V.I., Colombo L., Gellert P.R., Schwab M.G., Kim K. A roadmap for graphene. Nature, 2012, vol. 490, no. 7419, pp. 192-200, doi:https://doi.org/10.1038/nature11458.
36. Ji H., Sun H., Qu X. Antibacterial applications of graphene-based nanomaterials: Recent achievements and challenges. Adv. Drug Deliv. Rev., 2016, vol. 105, pp. 176-189, doi:https://doi.org/10.1016/j.addr.2016.04.009.
37. Bai R. G. Husseini G.A. Chapter 11 - Graphene-based drug delivery systems. Biomimetic Nanoengineered Materials for Advanced Drug Delivery, 2019, pp. 149-168, doi:https://doi.org/10.1016/B978-0-12-814944-7.00011-4.
38. Wu J. et al. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology, 2012, vol. 23, no. 35, doi:https://doi.org/10.1088/0957-4484/23/35/355101.
39. Costa F.J.P. et al. Development of Thiol-Maleimide hydrogels incorporating graphene-based nanomaterials for cancer chemo-photothermal therapy. Int. J. Pharm., 2023, vol. 635, no. February, doi:https://doi.org/10.1016/j.ijpharm.2023.122713.
40. Kuila T., Bose S., Khanra P., Mishra A.K., Kim N.H., Lee J.H. Recent advances in graphene-based biosensors. Biosens. Bioelectron., 2011, vol. 26, no. 12, pp. 4637-4648, doi:https://doi.org/10.1016/j.bios.2011.05.039.
41. Park J. et al. Graphene oxide flakes as a cellular adhesive: Prevention of reactive oxygen species mediated death of implanted cells for cardiac repair. ACS Nano, 2015, vol. 9, no. 5, pp. 4987-4999, doi:https://doi.org/10.1021/nn507149w.
